CorrlensCorrlens
Correlate

Correlation Analysis

Johnson & Johnson vs Medline Inc. Class A common stock

JNJ vs MDLN

+0.529

Moderate positive

When one moves up, the other tends to follow.

JNJ logo

Johnson & Johnson

JNJ

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Market cap 580.4B

M

Medline Inc. Class A common stock

MDLN

Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.

Market cap 35.6B · 45,000 employees

Dec 17, 2025 — Apr 7, 2026Daily75 data pointsStockStockHealthcare

Time Series

Relative Performance

Green: JNJGray: MDLN36 of 75 points (sampled)

Who Moves First

MDLN leads JNJ by 4 days

MDLN tends to move before JNJ.

After testing 13 timing shifts, the strongest relationship was +0.576 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

+0.537

9 periods · Return correlation when both series rose

Both Falling

+0.061

8 periods · Return correlation when both series fell

Diverging

-0.588

18 periods · Return correlation when series moved apart

R-Squared

28.0%

Share of variance in one series explained by the other.

Trend Agreement

58.1%

How often both series moved in the same direction period-to-period.

Overlap Quality

75

Thin shared window — 75 usable pairs.

Significance

p < 0.001

95% CI: [0.343, 0.675]

Scatter

XY Regression

200.8210220230240250252.138.1540424446485050.49Johnson & JohnsonMedline Inc. Class A common stockData pointsFit (r = 0.529)

Pipeline

Data quality details

Pipeline Summary

75 paired data points survived the daily window.

Raw input

1,254

75

Normalized

1,254

75

Prepared

1,254

75

Aligned

75

75

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

1,179

A: 1179 / B: 0

Series A

JNJ logo

Johnson & Johnson

JNJ

Market cap 580.4B

Stock · 1,254 raw → 1,254 prepared

Series B

M

Medline Inc. Class A common stock

MDLN

Market cap 35.6B · 45,000 employees

Stock · 75 raw → 75 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

1

Estimated crossover points between normalized spreads.

Slope

0.0850

Linear regression slope.

Intercept

24.3310

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 4 hours ago · ID: stock-jnj-vs-stock-mdln-daily